Your browser doesn't support javascript.
loading
Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER+ Breast Cancer.
Formisano, Luigi; Stauffer, Kimberly M; Young, Christian D; Bhola, Neil E; Guerrero-Zotano, Angel L; Jansen, Valerie M; Estrada, Mónica M; Hutchinson, Katherine E; Giltnane, Jennifer M; Schwarz, Luis J; Lu, Yao; Balko, Justin M; Deas, Olivier; Cairo, Stefano; Judde, Jean-Gabriel; Mayer, Ingrid A; Sanders, Melinda; Dugger, Teresa C; Bianco, Roberto; Stricker, Thomas; Arteaga, Carlos L.
Afiliación
  • Formisano L; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Stauffer KM; Department of Clinical Medicine, University of Naples Federico II, Naples, Italy.
  • Young CD; Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Bhola NE; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Guerrero-Zotano AL; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Jansen VM; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Estrada MM; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hutchinson KE; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Giltnane JM; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Schwarz LJ; Department of Pathology, Microbiology & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Lu Y; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Balko JM; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Deas O; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Cairo S; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Judde JG; Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Mayer IA; XenTech, Evry, France.
  • Sanders M; XenTech, Evry, France.
  • Dugger TC; LTTA Center, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
  • Bianco R; XenTech, Evry, France.
  • Stricker T; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Arteaga CL; Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Clin Cancer Res ; 23(20): 6138-6150, 2017 Oct 15.
Article en En | MEDLINE | ID: mdl-28751448
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Transcripción Genética / Neoplasias de la Mama / Resistencia a Antineoplásicos / Receptor alfa de Estrógeno / Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Transcripción Genética / Neoplasias de la Mama / Resistencia a Antineoplásicos / Receptor alfa de Estrógeno / Receptor Tipo 1 de Factor de Crecimiento de Fibroblastos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Female / Humans Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article